2BB score and signals
Monte Rosa Therapeutics, Inc.’s current 2BB score is 31 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 12 | Very Low |
| Momentum | 48 | Stable |
| Financial strength | 42 | Normal |
| Quality | 100 | Very Strong |
| Risk | 24 | Low |
Company facts
| Headquarters | Boston, Massachusetts, United States |
| Founded | 2019 |
| Employees | 187 |
| 52-week range | $4.12 – $25.77 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-04 | — | -0.4073 | — | $5.17M |
| 2026-08-06 | — | -0.3924 | — | $5.63M |
| 2026-05-06 | — | -0.4851 | — | $3.06M |
| 2026-03-12 | — | -0.3513 | — | $15.82M |
2BBBullish & Bearish